Explore resources for getting to Chicago and navigating the ASCO Annual Meeting online and in-person.

The Symposium Program Committee recognizes the importance of bringing together researchers to discuss ongoing trials. Trials in Progress abstracts provide an opportunity for members of the research ...

The MedOnc ITE is a low-stakes, 6-hour, 200-question exam intended for self-evaluation and program improvement. It is a teaching tool designed to provide a snapshot of trainee knowledge and program ...

The QOPI® Certification Program (QCP™) application is available in the ASCO Care Delivery Portal for new and re-certifying practices. For step-by-step application instructions, please refer to the QCP ...

ASCO Breakthrough gathers global oncology professionals in Asia, offering tailored scientific sessions, invaluable connections built on a shared purpose, and practical strategies to directly improve ...

SPARGO, Inc. is the only official registration and housing provider for ASCO Meetings and Symposia. Individuals unaffiliated with ASCO or SPARGO, Inc. may entice prospective attendees into registering ...

ASCO members are invited to help define the educational content for our flagship meetings. Through our new, unified submission portal, members can submit proposals that address the most critical needs ...

Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...

ASCO stands with our Ukrainian members, the worldwide oncology community, and health care providers around the globe in condemning Russia’s unprovoked war on Ukraine. We call for an immediate ...

Robin T. Zon, Erin B. Kennedy, Kerin Adelson, Sibel Blau, Natalie Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra Patt, Todd A ...

The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: The U.S. Food and Drug Administration (FDA) is providing this communication to increase ...